Category: review
-
Elderly people with type-2 diabetes mellitus(T2DM) and diabetic peripheral neuropathy (DPN) may be more prone to suffer severe injuries due to tripping and falling. A startling statistic reveals an older adults are admitted to hospitals every 13 seconds, on average, due to falls, while one death results from a fall every 20 minutes. A recent…
-
“There is a daunting list of toxins that can affect the peripheral nervous system,” according to a study published by Dr. Hani Kusiaf of the Department of Neurology at the Mayo Clinic in Minnesota. A host of potentially toxic neuropathy and myopathy drugs are unintentionally being released from research laboratories around the world, because the…
-
The FDA has approved alemtuzumab (Lemtrada) as a treatment for patients with multiple sclerosis. The FDA was careful to cite that use of alemtuzumab was a high-risk option since the drug may cause an increased risk for malignancies, including thyroid cancer, melanoma, lymphoproliferative disorders, neuropathy, which in some instances proved fatal. The medication is also marketed as Campath, which…
-
European scientists at the Pain Evaluation and Treatment Centre of Hôpital Ambroise Paré, evaluated several medications for neuropathic pain in an article partially titled “Pharmacotherapy for neuropathic pain in adults”. While research reports and findings are peer-reviewed for scientific correctness, the director of the center, Dr.Nadine Attal, finds certain biases creep into the picture. For…